1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Wenbin Qian: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma. Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells - B Cell Lymphoma | Phase 2 | Unknown | Wenbin Qian | 80 | 2019-03-28 | 2019-04-26 |
Lymphoma, B-Cell (1)
Chemokines (1) · Interleukin-7 (1)
China (1)